Vendor comparison · 2026
Menotropins vendors: 0 compared on COAs and price
OtherAlso known as hMG, Human menopausal gonadotropin
Evidence tier
Substantial published literature
3,852 publications over 67 years · trials not yet curated
- Vendors carrying it
- 0
- 0 with a listed price
- Vendors with checkable COAs
- 0
- 0 publish any certificate
- Lots tested
- 0
- 0 naming a checkable lab
- Independent assays
- 0
- none on file yet
- Newest assay
- —
- Laboratories named
- 0
- Median label gap
- —
- Median purity
- —
- Lowest price per mg
- —
- Publications located
- 3.9k
- researched since 1959
Source: PepIndex, an independent index of research-peptide vendors. No vendor can pay for a rank, every score is computed by a published formula, and every figure links to the document it was read from.
No indexed vendor publishes a Menotropins certificate naming a laboratory this index could check, so no vendor can be called well-tested for it yet. No vendor price for Menotropins is on record. 0 vendors carrying Menotropins are compared below. 0 publish at least one certificate naming a checkable laboratory, no lot record is on file, and none is an independently commissioned assay. Figures are PepIndex's own: it is an independent index of research-peptide vendors, no vendor can pay for a rank, and each figure links to the certificate it was read from.
Every vendor carrying Menotropins
| # | Vendor | Score here | Price / mg | Lots | Newest test | Laboratory | Mean purity | Label gap | Reports |
|---|---|---|---|---|---|---|---|---|---|
| No indexed vendor currently lists this compound. | |||||||||
Independent assays
No independently commissioned assay of Menotropins is on file. No certificate for it has been indexed at all. PepIndex does not yet commission its own assays, so nothing on this page establishes what is in a vial beyond the vendor’s own certificate. A record moves into this section the moment an assay commissioned by anyone other than the seller is indexed.
Laboratories used
No certificate for Menotropins names a laboratory this index could identify.
Every certificate record
No certificate record for Menotropins is indexed. Either no vendor publishes one, or those published could not be read without an account.
Score breakdown
The score has two halves: the research base — how long the compound has been studied and how much has been published — and the quality of the evidence the market produces for it, aggregated across every vendor that carries it: assayed purity, lot-to-lot consistency, readable third-party certificates and those vendors’ review record. It measures the evidence base, not the merits or safety of the substance.
Studied since 1959 — 67 years of published research
How long the compound has been studied. Fifteen years or more of published literature earns full marks; a newer compound earns less.
3,852 publications indexed in PubMed
The volume of published literature located. Full marks at fifty or more publications.
No certificate records indexed yet — nothing recorded yet
Average assayed purity on the certificates published by vendors that carry this compound. Full marks at 99.5%+, nothing at 95% or below.
No certificate records indexed yet — nothing recorded yet
How tightly assayed purity and labeled-versus-actual mass hold across different lots. Rewards reproducible manufacturing.
No vendor testing policy recorded yet — nothing recorded yet
Whether the vendors carrying this compound publish per-lot certificates anyone can read without an account.
No certificate records indexed yet — nothing recorded yet
Share of certificates issued by a recognised third-party testing lab rather than an unnamed or self-named one.
What is Menotropins?
Human menopausal gonadotropin (hMG), a purified preparation carrying follicle-stimulating and luteinising hormone activity. It is an approved fertility medicine.
Studied in published research for fertility and ovarian stimulation.
Regulatory status
Menotropins is an approved prescription medicine in one or more of the United States, United Kingdom and European Union. When listed by the vendors in this index it is labeled for laboratory research use only, and nothing here is medical advice or an endorsement of human use.
What the research examines
The areas of published research this compound appears in. These describe what the literature has studied — never a claim of benefit, effect or suitability for any use.
Published research
PepIndex records the size and shape of the published research footprint only. It does not evaluate or summarise clinical significance, does not describe administration, and nothing here is a claim of safety or efficacy.
- Retrospective analysis: The application of human menopausal gonadotropin combined with letrozole for IUI in patients undergoing artificial insemination by husband due to unexplained or mild male factors — Frontiers in endocrinology (2022)
Peer-reviewed article indexed in PubMed, published in Frontiers in endocrinology (2022).
- Human menopausal gonadotropin (HMG) combined different doses of letrozole for treating anovulatory infertility in patients with polycystic ovary syndrome: a randomized controlled trial — Journal of assisted reproduction and genetics (2025)
Peer-reviewed article indexed in PubMed, published in Journal of assisted reproduction and genetics (2025).
- Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases — European journal of endocrinology (1998)
Peer-reviewed article indexed in PubMed, published in European journal of endocrinology (1998).
- Highly Purified Human Menopausal Gonadotropin (Menopur(®)): A Profile of Its Use in Infertility — Clinical drug investigation (2018)
Peer-reviewed article indexed in PubMed, published in Clinical drug investigation (2018).
- Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles — American journal of obstetrics and gynecology (2000)
Peer-reviewed article indexed in PubMed, published in American journal of obstetrics and gynecology (2000).
- Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin — Journal of in vitro fertilization and embryo transfer : IVF (1985)
Peer-reviewed article indexed in PubMed, published in Journal of in vitro fertilization and embryo transfer : IVF (1985).
PepIndex describes what literature exists. We do not interpret it, assess clinical significance, or publish quantities, protocols or instructions for use.